Late Preterm Corticosteroids and Neonatal Hypoglycemia

• Status: Not yet recruiting
• Trial end date: 2024-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This is a prospective randomized controlled trial investigating the timing of betamethasone administration in late preterm infants in relation to delivery and impact on neonatal hypoglycemia. Previous data has shown that neonatal hypoglycemia is increased in late preterm infants that were exposed to antenatal corticosteroids. The investigators hypothesize that the timing of steroid administration may impact the development of neonatal hypoglycemia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Southern California
• Treatments: Betamethasone; Betamethasone benzoate; Betamethasone sodium phosphate; Betamethasone Valerate; Betamethasone-17,21-dipropionate

Criteria

Inclusion Criteria:

• Singleton pregnancy

• Gestational age 34 0/7 weeks to 36 5/7 weeks

• Planned delivery in late preterm period

Exclusion Criteria:

• Prior course of betamethasone during pregnancy

• Twin gestation

• Fetal demise

• Major fetal anomaly

• Maternal contraindication to betamethasone

• Pregestational diabetes

• Expected delivery within 12 hours of randomization